rs2276061

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378964.1(CDON):​c.3549C>T​(p.Val1183Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.302 in 1,613,642 control chromosomes in the GnomAD database, including 75,680 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5470 hom., cov: 33)
Exomes 𝑓: 0.31 ( 70210 hom. )

Consequence

CDON
NM_001378964.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0530

Publications

24 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
CDON Gene-Disease associations (from GenCC):
  • holoprosencephaly 11
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 11-125961806-G-A is Benign according to our data. Variant chr11-125961806-G-A is described in ClinVar as Benign. ClinVar VariationId is 260797.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.053 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.309 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDONNM_001378964.1 linkc.3549C>T p.Val1183Val synonymous_variant Exon 19 of 20 ENST00000531738.6 NP_001365893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDONENST00000531738.6 linkc.3549C>T p.Val1183Val synonymous_variant Exon 19 of 20 1 NM_001378964.1 ENSP00000432901.2 Q4KMG0-2E9PN78

Frequencies

GnomAD3 genomes
AF:
0.255
AC:
38709
AN:
151982
Hom.:
5468
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.302
Gnomad AMR
AF:
0.264
Gnomad ASJ
AF:
0.294
Gnomad EAS
AF:
0.283
Gnomad SAS
AF:
0.314
Gnomad FIN
AF:
0.319
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.312
Gnomad OTH
AF:
0.251
GnomAD2 exomes
AF:
0.290
AC:
72946
AN:
251112
AF XY:
0.296
show subpopulations
Gnomad AFR exome
AF:
0.122
Gnomad AMR exome
AF:
0.276
Gnomad ASJ exome
AF:
0.287
Gnomad EAS exome
AF:
0.274
Gnomad FIN exome
AF:
0.317
Gnomad NFE exome
AF:
0.309
Gnomad OTH exome
AF:
0.306
GnomAD4 exome
AF:
0.307
AC:
449354
AN:
1461542
Hom.:
70210
Cov.:
37
AF XY:
0.308
AC XY:
224079
AN XY:
727070
show subpopulations
African (AFR)
AF:
0.116
AC:
3891
AN:
33478
American (AMR)
AF:
0.274
AC:
12264
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.295
AC:
7710
AN:
26136
East Asian (EAS)
AF:
0.279
AC:
11091
AN:
39694
South Asian (SAS)
AF:
0.318
AC:
27440
AN:
86248
European-Finnish (FIN)
AF:
0.311
AC:
16627
AN:
53404
Middle Eastern (MID)
AF:
0.251
AC:
1445
AN:
5768
European-Non Finnish (NFE)
AF:
0.316
AC:
350788
AN:
1111728
Other (OTH)
AF:
0.300
AC:
18098
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
17151
34301
51452
68602
85753
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11392
22784
34176
45568
56960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.255
AC:
38729
AN:
152100
Hom.:
5470
Cov.:
33
AF XY:
0.257
AC XY:
19090
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.126
AC:
5228
AN:
41504
American (AMR)
AF:
0.264
AC:
4035
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
1021
AN:
3472
East Asian (EAS)
AF:
0.283
AC:
1459
AN:
5156
South Asian (SAS)
AF:
0.314
AC:
1511
AN:
4808
European-Finnish (FIN)
AF:
0.319
AC:
3371
AN:
10554
Middle Eastern (MID)
AF:
0.259
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
0.312
AC:
21224
AN:
68002
Other (OTH)
AF:
0.250
AC:
529
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1421
2842
4262
5683
7104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.291
Hom.:
10507
Bravo
AF:
0.246
Asia WGS
AF:
0.271
AC:
944
AN:
3478
EpiCase
AF:
0.311
EpiControl
AF:
0.314

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Holoprosencephaly 11 Benign:3
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Dec 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.34
DANN
Benign
0.71
PhyloP100
-0.053
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276061; hg19: chr11-125831701; COSMIC: COSV54997153; COSMIC: COSV54997153; API